- Home
- ICLR
ICLR
ICON plc
as 04-18-2025 1:37pm EST
| Founded: | 1990 | Country: | Ireland |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 1998 |
| Target Price: | $225.55 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 9.53 | EPS Growth: | 28.78 |
| 52 Week Low/High: | $138.51 - $347.72 | Next Earning Date: | 04-30-2025 |
| Revenue: | $8,281,675,999 | Revenue Growth: | 1.99% |
| Revenue Growth (this year): | 2.33% | Revenue Growth (next year): | 5.11% |
Latest ICON plc News
ICLR Breaking Stock News: Dive into ICLR Ticker-Specific Updates for Smart Investing
Insider Monkey
9 days ago
What Makes Icon PLC (ICLR) an Investment Bet?
GlobeNewswire
16 days ago
Anne Whitaker Appointed as Non-Executive Director
Insider Monkey
16 days ago
Is ICON Public Limited Company (ICLR) The Best Beaten Down Stock to Buy According to Analysts?
Insider Monkey
16 days ago
LVS Advisory Sold Icon Plc (ICLR) After Identifying Flaws in its Investment Thesis
Business Wire
19 days ago
ICON plc Schedules First Quarter 2025 Earnings Conference Call
PR Newswire
a month ago
BetterInvesting™ Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR)
Insider Monkey
a month ago
Is ICON Public Limited Company (ICLR) the Best Diagnostics Stock to Invest in Right Now?
Insider Monkey
a month ago
ICON Public Limited Company (ICLR) Leverages AI-Powered Medidata Platform to Optimize Clinical Trials
Compare ICLR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ICLR ICON plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.